• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因子V浓度降低和FV1/FV2比率改变并不能完全解释与R2相关的活化蛋白C抵抗。

Reduced factor V concentration and altered FV1/FV2 ratio do not fully explain R2-associated APC-resistance.

作者信息

Govers-Riemslag José W P, Castoldi Elisabetta, Nicolaes Gerry A F, Tans Guido, Rosing Jan

机构信息

Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands.

出版信息

Thromb Haemost. 2002 Sep;88(3):444-9.

PMID:12353074
Abstract

Carriership of the factor V (FV) R2 haplotype is associated with mild APC-resistance, moderately reduced FV levels and a relative increase of the more thrombogenic FV isoform, FV1. Since low FV levels and increased FV1 can theoretically cause APC-resistance, we investigated whether these alterations can quantitatively account for R2-associated APC-resistance. In order to determine the effect of FV concentration and FV isoform composition on the APC-response, we reconstituted FV-deficient plasma with purified FV1 and FV2 in different molar ratios and to varying FV concentrations. APC sensitivity ratios (APCsr) were determined with the Coatest APC Resistance V, which probes the effect of APC on both FVa- and FVIIIa-inactivation, and with the Immunochrom APC response test, which only quantifies the effect of APC on FVIII(a)-inactivation. In both assays, low FV concentrations and/or high relative amounts of FV1 rendered plasma samples more resistant to APC. APCsr were also determined in FV-deficient plasma reconstituted with purified FV at levels and isoform ratios observed in R2-homozygotes (98% FV, 42% FV1) and age-matched controls (119% FV, 26% FV1). In both tests the APCsr of reconstituted control plasma was the same as that of plasma from controls, whereas reconstituted R2-plasma was less APC-resistant than plasma from homozygous carriers of the R2 haplotype. We conclude that the low FV levels and altered FV isoform ratio cannot fully explain R2-associated APC-resistance.

摘要

因子 V(FV)R2 单倍型的携带与轻度活化蛋白 C(APC)抵抗、FV 水平适度降低以及更具血栓形成性的 FV 异构体 FV1 的相对增加有关。由于低 FV 水平和 FV1 增加理论上可导致 APC 抵抗,我们研究了这些改变是否能定量解释与 R2 相关的 APC 抵抗。为了确定 FV 浓度和 FV 异构体组成对 APC 反应的影响,我们用不同摩尔比的纯化 FV1 和 FV2 以及不同的 FV 浓度重构 FV 缺乏的血浆。使用检测 APC 对 FVa 和 FVIIIa 失活作用的 Coatest APC Resistance V 和仅定量 APC 对 FVIII(a)失活作用的免疫层析 APC 反应试验来测定 APC 敏感性比值(APCsr)。在这两种试验中,低 FV 浓度和/或高相对量的 FV1 使血浆样本对 APC 的抵抗性更强。还在以 R2 纯合子(98% FV,42% FV1)和年龄匹配对照(119% FV,26% FV1)中观察到的水平和异构体比例用纯化 FV 重构的 FV 缺乏血浆中测定了 APCsr。在这两种试验中,重构对照血浆的 APCsr 与对照血浆的相同,而重构的 R2 血浆对 APC 的抵抗性低于来自 R2 单倍型纯合携带者的血浆。我们得出结论,低 FV 水平和改变的 FV 异构体比例不能完全解释与 R2 相关的 APC 抵抗。

相似文献

1
Reduced factor V concentration and altered FV1/FV2 ratio do not fully explain R2-associated APC-resistance.因子V浓度降低和FV1/FV2比率改变并不能完全解释与R2相关的活化蛋白C抵抗。
Thromb Haemost. 2002 Sep;88(3):444-9.
2
Functional properties of factor V and factor Va encoded by the R2-gene.由R2基因编码的凝血因子V和凝血因子Va的功能特性。
Thromb Haemost. 2001 Jan;85(1):75-81.
3
An assay to quantify the two plasma isoforms of factor V.一种定量凝血因子V两种血浆同工型的检测方法。
Thromb Haemost. 2000 Dec;84(6):1066-71.
4
Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.在 TFPIα 的存在下,因子 V 在血浆中具有抗凝活性:FV1 和 FV2 之间的差异。
Thromb Haemost. 2018 Jul;118(7):1194-1202. doi: 10.1055/s-0038-1656549. Epub 2018 Jun 4.
5
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.正常因子V等位基因的表达可调节因子V莱顿突变杂合携带者的APC抵抗表型。
J Thromb Haemost. 2005 Dec;3(12):2695-702. doi: 10.1111/j.1538-7836.2005.01634.x.
6
The R2-haplotype associated Asp2194Gly mutation in the light chain of human factor V results in lower expression levels of FV, but has no influence on the glycosylation of Asn2181.与R2单倍型相关的人因子V轻链中的Asp2194Gly突变导致FV表达水平降低,但对Asn2181的糖基化没有影响。
Thromb Haemost. 2003 Mar;89(3):429-37.
7
Determination of activated protein C resistance in anticoagulated and lupus positive patients.抗凝及狼疮阳性患者中活化蛋白C抵抗的测定
Blood Coagul Fibrinolysis. 2000 Jul;11(5):439-45. doi: 10.1097/00001721-200007000-00007.
8
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma.
Thromb Haemost. 2000 Mar;83(3):362-5.
9
Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.在因子Va失活过程中,因子V是活化蛋白C的抗凝辅因子。
Pathophysiol Haemost Thromb. 2010;37(1):17-23. doi: 10.1159/000315141. Epub 2010 May 22.
10
Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.因子V的活化蛋白C(APC)辅助因子活性受损在与因子V莱顿(R506Q)和R2(H1299R)突变相关的APC抵抗中起主要作用。
Blood. 2004 Jun 1;103(11):4173-9. doi: 10.1182/blood-2003-10-3578. Epub 2004 Feb 19.

引用本文的文献

1
Factor V variants in bleeding and thrombosis.出血和血栓形成中的凝血因子V变体
Res Pract Thromb Haemost. 2024 Jan 26;8(1):102330. doi: 10.1016/j.rpth.2024.102330. eCollection 2024 Jan.